Skip to main content

Findell Capital Management LLC

13F filer · CIK 0001814465
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$710MU.S. long equity reported on 13F
Positions122 new · 7 closed
Net flow last quarter+$31.5MBuys minus sells
Top 10 positions weight82.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202612 positions
LQDALiquidia Corp$279M39.31%3.93%Not reportedQ4 2023
ESTAEstablishment Labs Holdings Inc.$94M13.24%3.68%+9.9%Q4 2023
DAVEDave Inc.$54M7.61%Not reported-14.7%Q3 2025
SGHCSuper Group (SGHC) Ltd$28.5M4.01%0.42%+40.0%Q3 2025
ROOTRoot, Inc.$25.7M3.62%19.48%+22.7%Q2 2025
ABVXAbivax S.A.$24.7M3.47%0.24%+76.2%Q3 2025
GEOGeo Group Inc$23.6M3.33%0.60%-8.6%Q4 2024
CELHCelsius Holdings, Inc.$22M3.09%0.30%+275.0%Q4 2024
OPRTOportun Financial Corp$16M2.25%6.09%+1.8%Q4 2023
TPBTurning Point Brands, Inc.$14.4M2.03%0.88%+79.0%Q3 2025
FIGFigma, Inc.$13.5M1.90%Not reportedNewQ2 2026
RKTRocket Companies, Inc.$11M1.55%Not reportedNewQ2 2026
Q1 2026Reported May 15, 202617 positions
LQDALiquidia Corp$132M38.71%3.97%+22.8%Q4 2023
ESTAEstablishment Labs Holdings Inc.$56.7M16.59%3.40%-11.7%Q4 2023
DAVEDave Inc.$29.6M8.67%Not reported+142.9%Q3 2025
ROOTRoot, Inc.$16.6M4.85%15.88%+59.6%Q2 2025
SGHCSuper Group (SGHC) Ltd$16.2M4.74%0.30%+59.6%Q3 2025
GEOGeo Group Inc$14.7M4.31%0.65%+34.6%Q4 2024
OPRTOportun Financial Corp$12.7M3.71%6.03%+7.0%Q4 2023
ABVXAbivax S.A.$11.7M3.42%0.13%+118.8%Q3 2025
CVECenovus Energy Inc.$9.95M2.91%0.02%NewQ1 2026
ACHCAcadia Healthcare Company, Inc.$8.89M2.60%0.42%NewQ1 2026
TPBTurning Point Brands, Inc.$8.25M2.41%0.50%-25.2%Q3 2025
CELHCelsius Holdings, Inc.$7.1M2.08%0.08%-4.8%Q4 2024
MLYSMineralys Therapeutics, Inc.$5.47M1.60%0.25%+304.0%Q1 2025
VETVermilion Energy Inc.$5.1M1.49%0.24%Not reportedQ4 2023
APLDApplied Digital Corp.$4.04M1.18%0.06%Not reportedQ3 2024
BTUPeabody Energy Corp$276K0.08%0.01%Not reportedQ3 2025
EHTHeHealth, Inc.$231K0.07%0.58%-87.3%Q4 2023
Q4 2025Reported Feb 17, 202615 positions
LQDALiquidia Corp$98.3M28.28%3.27%+0.8%Q4 2023
ESTAEstablishment Labs Holdings Inc.$82.4M23.69%3.86%-12.7%Q4 2023
ROOTRoot, Inc.$17M4.88%9.95%+291.7%Q2 2025
DAVEDave Inc.$15.5M4.46%Not reported+84.2%Q3 2025
TPBTurning Point Brands, Inc.$13.8M3.96%0.67%+41.1%Q3 2025
OPRTOportun Financial Corp$13.6M3.91%5.78%Not reportedQ4 2023
SGHCSuper Group (SGHC) Ltd$11.2M3.23%0.19%+40.3%Q3 2025
GEOGeo Group Inc$10.5M3.01%0.48%+16.1%Q4 2024
CELHCelsius Holdings, Inc.$9.61M2.76%0.08%Not reportedQ4 2024
EHTHeHealth, Inc.$6.48M1.86%4.55%+15.0%Q4 2023
ABVXAbivax S.A.$6.47M1.86%0.06%+20.0%Q3 2025
LRNStride, Inc.$5.84M1.68%0.21%NewQ4 2025
ADMAAdma Biologics, Inc.$5.47M1.57%0.13%NewQ4 2025
VORVor Biopharma Inc.$3.02M0.87%0.60%NewQ4 2025
MLYSMineralys Therapeutics, Inc.$1.81M0.52%0.06%-80.0%Q1 2025
Q3 2025Reported Nov 14, 202513 positions
LQDALiquidia Corp$64.4M25.40%3.26%-5.7%Q4 2023
ESTAEstablishment Labs Holdings Inc.$53.1M20.96%4.46%-6.1%Q4 2023
OPRTOportun Financial Corp$15.8M6.25%5.82%-9.5%Q4 2023
GEOGeo Group Inc$11.5M4.53%0.40%-3.5%Q4 2024
MLYSMineralys Therapeutics, Inc.$9.48M3.74%0.32%Not reportedQ1 2025
TPBTurning Point Brands, Inc.$8.9M3.51%0.50%NewQ3 2025
SGHCSuper Group (SGHC) Ltd$8.85M3.49%0.13%NewQ3 2025
DAVEDave Inc.$7.58M2.99%Not reportedNewQ3 2025
BTUPeabody Energy Corp$6.23M2.46%0.19%NewQ3 2025
ROOTRoot, Inc.$5.37M2.12%2.54%-31.8%Q2 2025
EHTHeHealth, Inc.$5.28M2.08%4.01%+2.1%Q4 2023
SEZLSezzle Inc.$4.29M1.70%0.16%NewQ3 2025
ABVXAbivax S.A.$3.4M1.34%0.06%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.